OverviewChartNewsTraderScreen

Vaxart/  US92243A2006  /

IEX
2024-05-21  4:46:52 PM Chg. -0.04 Volume Bid- Ask- High Low
0.86USD -4.04% 1,389
Turnover: 1,197.98		 -Bid Size: - -Ask Size: - 0.89 0.86
GlobeNewswire 05-13 Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 05-07 Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13
GlobeNewswire 04-30 Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
GlobeNewswire 03-27 Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
GlobeNewswire 03-20 Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 03-14 Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
GlobeNewswire 03-07 Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
GlobeNewswire 03-06 Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
GlobeNewswire 02-05 Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Nex...
GlobeNewswire 01-19 Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Eva...
GlobeNewswire 01-16 Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
GlobeNewswire 01-16 Vaxart, Inc. Announces Management Change
GlobeNewswire 2023-12-21 Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating...
GlobeNewswire 2023-11-02 Vaxart Provides Business Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-02 Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers
GlobeNewswire 2023-10-26 Vaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November ...
GlobeNewswire 2023-10-11 Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19
GlobeNewswire 2023-09-21 Vaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare Conference
GlobeNewswire 2023-09-06 Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine C...
TeleTrader 2023-06-06 Vaxart commences public offering of common stock
TeleTrader 2022-09-01 Vaxart jumps 10% on pill COVID vaccine results
GlobeNewswire 2022-02-24 Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-02-14 Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
GlobeNewswire 2022-01-04 Vaxart to Participate at the H.C. Wainwright BioConnect Virtual Conference
GlobeNewswire 2021-12-16 Vaxart to Test Cross-Reactivity of its COVID-19 Oral Tablet Vaccine Against Omicron